Muscular tumor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:206982
Who is this for?
Show terms as
3Active trials47Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Muscular tumor, also known as myoma, is a rare benign (non-cancerous) growth that develops from muscle tissue. These tumors can arise from smooth muscle (called leiomyomas) or from skeletal muscle (called rhabdomyomas). They can occur in various parts of the body, including the uterus, skin, gastrointestinal tract, or other organs that contain muscle tissue. While the most well-known type of muscular tumor is the uterine fibroid (uterine leiomyoma), the Orphanet classification under code 206982 refers to a broader and rarer category of muscular tumors that may appear in unusual locations. Symptoms depend heavily on where the tumor grows. A muscular tumor in the skin may appear as a firm lump that can sometimes be painful, especially when exposed to cold. Tumors in internal organs may cause pressure symptoms, pain, or dysfunction of nearby structures. Most muscular tumors grow slowly and do not spread to other parts of the body. Treatment typically involves monitoring the tumor if it is small and not causing problems. Surgical removal is the main treatment when the tumor causes symptoms or grows significantly. In most cases, the outlook is very good because these tumors are benign. However, in rare instances, it is important to distinguish a benign muscular tumor from a malignant (cancerous) counterpart such as leiomyosarcoma or rhabdomyosarcoma, which require more aggressive treatment.

Key symptoms:

A firm lump or mass under the skin or in deeper tissuesPain or tenderness at the site of the tumorIncreased sensitivity to cold at the tumor sitePressure on nearby organs or structuresAbdominal pain or discomfort if the tumor is in the belly areaDifficulty with normal organ function depending on tumor locationSlow-growing painless massSkin discoloration over the tumor areaFeeling of fullness or bloating if in the abdomen

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Sep 2026Personalized Care Management Model (GAP-421) for Chronic Pain in Primary Care Physiotherapy

Universidad Autonoma de Madrid — NA

TrialNOT YET RECRUITING
Sep 2026Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer

Universidad Europea de Madrid — NA

TrialNOT YET RECRUITING
Jun 2026Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer

Brazilian Clinical Research Institute — NA

TrialNOT YET RECRUITING
May 2026Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer

University of Florida — NA

TrialNOT YET RECRUITING
May 2026Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Protara Therapeutics — PHASE3

TrialNOT YET RECRUITING
Apr 2026Personalized Cooking and Nutrition Guidance and Physical Activities Program to Reduce Muscle Loss in Advanced Cancer

Gali Perel — NA

TrialNOT YET RECRUITING
Apr 2026Exercise for the Treatment of Cancer-Related Sarcopenia

State University of Londrina — NA

TrialNOT YET RECRUITING
Apr 2026Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer

University of Wisconsin, Madison — PHASE1

TrialNOT YET RECRUITING
Mar 2026Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

University of Sao Paulo — NA

TrialNOT YET RECRUITING
Feb 2026Promoting Active Living Among People With Metastatic Breast Cancer

University of Oklahoma — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Muscular tumor.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
N/A2 trials
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
N/A
Actively Recruiting
· Sites: Ghent · Age: 1845 yrs
Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy
N/A
Actively Recruiting
· Sites: Alexandria, El-Shatby; Alexandria, Smouha
Other1 trial
Are Uterine Fibroids Pro-thrombotic?
Active
· Sites: London · Age: 1865 yrs

Specialists

Showing 25 of 47View all specialists →
GL
Global Clinical Leader
Specialist
PI on 44 active trials4 Muscular tumor publications
GM
Giuseppe Procopio, MD
RAHWAY, NJ
Specialist
PI on 8 active trials1 Muscular tumor publication
YS
Yoshitaka Shimizu
Specialist
PI on 4 active trials61 Muscular tumor publications
SS
Scott Schuetze
ANN ARBOR, MI
Specialist
PI on 3 active trials
KG
Kan Gong
NEW YORK, NY
Specialist
PI on 3 active trials9 Muscular tumor publications
SM
Samuel Funt, MD
NEW YORK, NY
Specialist
PI on 3 active trials
LM
Lawrence C Hurst, MD
Specialist
PI on 1 active trial1 Muscular tumor publication
DM
Daniel Castellano, MD
Specialist
PI on 1 active trial
CM
Charlotte Owens, MD
MIAMISBURG, OH
Specialist
PI on 1 active trial
BM
Bernard Bochner, MD
NEW YORK, NY
Specialist
PI on 1 active trial
SP
Stefano Uccella, MD, PhD
Specialist
PI on 1 active trial
PM
Pier Carlo Zorzato, MD
Specialist
PI on 1 active trial
MM
Max Kates, MD
BALTIMORE, MD
Specialist
PI on 2 active trials
SM
Simone Garzon, MD
Specialist
PI on 1 active trial
ID
Ilse Degreef, Prof. Dr.
Specialist
PI on 3 active trials
VM
Veronica Urdaneta, MD
Specialist
PI on 2 active trials
SM
Sabine Brookman-May, Professor, Dr. med.
Specialist
PI on 1 active trial
GM
Galip Can Uyar, MD
Specialist
PI on 3 active trials1 Muscular tumor publication
AF
Alessandro FASCIANI
Specialist
PI on 1 active trial1 Muscular tumor publication
MP
Meral Boşnak Güçlü, Assoc. Prof
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Muscular tumor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Muscular tumorForum →

No community posts yet. Be the first to share your experience with Muscular tumor.

Start the conversation →

Latest news about Muscular tumor

Disease timeline:

New recruiting trial: Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: Pre-pectoral Tissue Expander and Acellular Dermal Matrix for a Two-stage Muscle Sparing Breast Reconstruction

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: QL Block in Laparoscopic Myomectomy

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: Metabolism, Circadian Rhythms and Ovarian Function

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: Nanshan Elderly Cohort Study

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

A new clinical trial is recruiting patients for Muscular tumor

New recruiting trial: A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

A new clinical trial is recruiting patients for Muscular tumor

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is my muscular tumor benign, and how can you be sure it is not cancerous?,Do I need a biopsy, or can imaging alone confirm the diagnosis?,Should I have the tumor removed, or is it safe to monitor it over time?,Could this tumor be part of a hereditary condition, and should my family members be tested?,What are the chances the tumor will come back after removal?,Are there any lifestyle changes I should make to manage symptoms?,How often should I have follow-up imaging or check-ups?

Common questions about Muscular tumor

What is Muscular tumor?

Muscular tumor, also known as myoma, is a rare benign (non-cancerous) growth that develops from muscle tissue. These tumors can arise from smooth muscle (called leiomyomas) or from skeletal muscle (called rhabdomyomas). They can occur in various parts of the body, including the uterus, skin, gastrointestinal tract, or other organs that contain muscle tissue. While the most well-known type of muscular tumor is the uterine fibroid (uterine leiomyoma), the Orphanet classification under code 206982 refers to a broader and rarer category of muscular tumors that may appear in unusual locations. Sym

Are there clinical trials for Muscular tumor?

Yes — 3 recruiting clinical trials are currently listed for Muscular tumor on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Muscular tumor?

25 specialists and care centers treating Muscular tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.